Experience

Checkmab

• Italy
• Biotechnology Research
• 1 - 100 Employee

• Senior Scientist

  • Jan 2020 - Present

  Characterization and validation of therapeutic monoclonal antibodies generate against tumor-infiltrating regulatory T lymphocytes (Tregs) for cancer immunotherapy Characterization and validation of therapeutic monoclonal antibodies generate against tumor-infiltrating regulatory T lymphocytes (Tregs) for cancer immunotherapy



Università Cattolica del Sacro Cuore

• Higher Education
• 700 & Above Employee

• Research Associate

  • Jan 2017 - Dec 2019

  Development of novel CSCs-specific mAbs as biomarkers and therapeutics for colorectal cancer Development of novel CSCs-specific mAbs as biomarkers and therapeutics for colorectal cancer



LifeArc

• United Kingdom
• Non-profit Organizations
• 200 - 300 Employee

• Visiting Scientist

  • Feb 2018 - Dec 2018

  Preclinical development of a monoclonal antibodies-drug conjugated as targeted therapy for colorectal cancer Preclinical development of a monoclonal antibodies-drug conjugated as targeted therapy for colorectal cancer



Regina Elena National Cancer Institute and National Institute of Health

• Post Doctoral Researcher

  • Jan 2012 - Dec 2016

  Research projects: - Generation, screening and characterization of new monoclonal antibodies direct against epitopes expressed on colon cancer stem like cells to be used as new tools for colon cancer diagnosis, prognosis and therapy - Generation of a Full Length cDNA Library for the identification of colon cancer stem cell antigens Research projects: - Generation, screening and characterization of new monoclonal antibodies direct against epitopes expressed on colon cancer stem like cells to be used as new tools for colon cancer diagnosis, prognosis and therapy - Generation of a Full Length cDNA Library for the identification of colon cancer stem cell antigens



National Institute of Health, Rome

• PHD Student

  • Oct 2007 - Dec 2011

  Identification of microRNA involved in colon cancer tumour development Identification of microRNA involved in colon cancer tumour development



St. Orsola General Hospital, Bologna

• PHD Student

  • Nov 2006 - May 2007

  Identification and characterization of molecular therapy based on modified oligonucleotides for the treatment of childhood solid tumors. Identification and characterization of molecular therapy based on modified oligonucleotides for the treatment of childhood solid tumors.



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Stage

  • Feb 2006 - Aug 2006

  Assessment of B memory lymphocyte responses following vaccination. Assessment of B memory lymphocyte responses following vaccination.

• Graduation Thesis

  • Apr 2004 - Jul 2005

  Molecular characterization of the UL53 gene product from HCMV: localization study by means of specific antibody. Molecular characterization of the UL53 gene product from HCMV: localization study by means of specific antibody.